Results 131 to 140 of about 1,605,786 (390)

Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases, 2020
Background Circulating tumor cells (CTCs) are frequently detected in patients with advanced-stage malignant tumors and could act as a predictor of poor prognosis.
Byung Ju Kang, M.D., Ph.D., Seung Won Ra, M.D., Ph.D.,, Kyusang Lee, Ph.D., Soyeoun Lim, M.D., M.S., So Hee Son, M.S., Jong-Joon Ahn, M.D., Ph.D., Byung Chul Kim, Ph.D.   +6 more
doaj  

Dynamic gene screening enabled identification of a 10-gene panel for early detection and progression assessment of gastric cancer

Computational and Structural Biotechnology Journal, 2023
Early diagnosis and progression assessment are critical for the timely detection and treatment of gastric cancer (GC) patients. Identification of diagnostic biomarkers for early detection of GC represents an unmet clinical need, and how these markers ...
Fei Long, Shuo Li, Yaqi Xu, Min Liu, Xuan Zhang, Junting Zhou, Yiyi Chen, Yuan Rong, Xiangyu Meng, Fubing Wang   +9 more
doaj  

THE VITAL STAINING OF MUSCLE BIOPSIES WITH METHYLENE BLUE [PDF]

, 1952
Christian Coërs
openalex   +1 more source

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Journal of Clinical Oncology, 2015
PURPOSE An increasing proportion of patients (> 30%) with node-positive breast cancer will obtain an axillary pathologic complete response after neoadjuvant chemotherapy (NAC).
J. Boileau, B. Poirier, M. Basik, C. Holloway, L. Gaboury, L. Sidéris, S. Meterissian, A. Arnaout, M. Brackstone, D. McCready, S. Karp, I. Trop, A. Lisbona, F. Wright, R. Younan, L. Provencher, E. Patocskai, A. Omeroglu, A. Robidoux   +18 more
semanticscholar   +1 more source

The roles and applications of extracellular vesicles in cancer

Molecular Oncology, EarlyView.
Extracellular vesicles (EVs) are minute versions of cells limited by a lipid bilayer containing cytoplasm from the cell that releases them, but without a nucleus and thus unable to self‐reproduce. EVs contain multiple molecules (proteins, lipids, glycans, and nucleic acids) they can induce complex responses in cells.
Clotilde Théry, Daniel Louvard
wiley   +1 more source

Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study.

JAMA Surgery, 2019
Importance Magnetic resonance imaging (MRI) guidance improves the accuracy of prostate biopsy for the detection of clinically significant prostate cancer, but the optimal use of such guidance is not yet clear.
Fuad F. Elkhoury, E. Felker, L. Kwan, A. Sisk, Merdie K. Delfin, S. Natarajan, L. Marks   +6 more
semanticscholar   +1 more source

Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic cancer precursors

Molecular Oncology, EarlyView.
Combining melting curve analysis enhances the multiplexing capability of digital PCR. Here, we developed a 14‐plex assay to simultaneously measure single nucleotide mutations and amplifications of KRAS and GNAS, which are common driver genes in pancreatic cancer precursors. This assay accurately quantified variant allele frequencies in clinical samples
Junko Tanaka, Tatsuo Nakagawa, Yusuke Ono, Yoshio Kamura, Takeshi Ishida, Hidemasa Kawabata, Kenji Takahashi, Hiroki Sato, Andrew S. Liss, Yusuke Mizukami, Takahide Yokoi   +10 more
wiley   +1 more source

Needle Biopsy of the Parietal Pleura in Malignant Disease [PDF]

, 1959
P. O. Leggat
openalex   +1 more source

A comment on the paper Prediction of Kidney Function from Biopsy Images using Convolutional Neural Networks [PDF]

arXiv, 2017
This letter presente a comment on the paper Prediction of Kidney Function from Biopsy Images using Convolutional Neural Networks by Ledbetter et al. (2017)
arxiv  

Circulating tumor DNA as a liquid biopsy for cancer.

Clinical Chemistry, 2015
BACKGROUND Targeted therapies have markedly changed the treatment of cancer over the past 10 years. However, almost all tumors acquire resistance to systemic treatment as a result of tumor heterogeneity, clonal evolution, and selection.
E. Heitzer, Peter Ulz, J. Geigl
semanticscholar   +1 more source